Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Influence of Intranasal Drugs on Human Nasal Mucociliary Clearance and Ciliary Beat Frequency
Jian Jiao, Luo Zhang
Allergy Asthma and Immunology Research (2019) Vol. 11, Iss. 3, pp. 306-306
Open Access | Times Cited: 52

Showing 1-25 of 52 citing articles:

Intranasal drug delivery: opportunities and toxicologic challenges during drug development
Lea-Adriana Keller, Olivia M. Merkel, Andreas Popp
Drug Delivery and Translational Research (2021) Vol. 12, Iss. 4, pp. 735-757
Open Access | Times Cited: 384
The Relationship between Fine Particle Matter (PM2.5) Exposure and Upper Respiratory Tract Diseases
Łukasz Zaręba, Katarzyna Piszczatowska, Karolina Dżaman, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 1, pp. 98-98
Open Access | Times Cited: 16
Intranasal nanotherapeutics for brain targeting and clinical studies in Parkinson's disease
Paramita Saha‐Chaudhuri, Himanshu Kathuria, Murali Monohar Pandey
Journal of Controlled Release (2023) Vol. 358, pp. 293-318
Closed Access | Times Cited: 30
Swimming short fibrous nasal drops achieving intraventricular administration
Juan Wang, Qiuyun Wang, Yifei Fu, et al.
Science Bulletin (2024) Vol. 69, Iss. 9, pp. 1249-1262
Closed Access | Times Cited: 12
The Significance of Fractional Exhaled Nitric Oxide, Fractional Nasal Exhaled Nitric Oxide and Lung Function Tests in Children with Moderate-to-Severe Allergic Rhinitis
Wanying Li, Wanyu Jia, Xiaowen Yi, et al.
American Journal of Rhinology and Allergy (2025)
Closed Access | Times Cited: 1
Development and Characterization of In Situ Gelling Nasal Cilostazol Spanlastics
Maryana Salamah, Mária Budai-Szűcs, Bence Sipos, et al.
Gels (2025) Vol. 11, Iss. 2, pp. 82-82
Open Access | Times Cited: 1
Nitric oxide and viral infection: Recent developments in antiviral therapies and platforms
Mark Garren, Morgan Ashcraft, Yun Qian, et al.
Applied Materials Today (2020) Vol. 22, pp. 100887-100887
Open Access | Times Cited: 64
Carrageenan-containing over-the-counter nasal and oral sprays inhibit SARS-CoV-2 infection of airway epithelial cultures
Desirée Schütz, Carina Conzelmann, Giorgio Fois, et al.
AJP Lung Cellular and Molecular Physiology (2021) Vol. 320, Iss. 5, pp. L750-L756
Open Access | Times Cited: 55
Convolutions in the rendition of nose to brain therapeutics from bench to bedside: Feats & fallacies
Honey Goel, Vinni Kalra, Sant Kumar Verma, et al.
Journal of Controlled Release (2021) Vol. 341, pp. 782-811
Closed Access | Times Cited: 32
Nanotechnology-Based Therapeutics for Airway Inflammatory Diseases
Limei Cui, Yujuan Yang, Hao Yan, et al.
Clinical Reviews in Allergy & Immunology (2025) Vol. 68, Iss. 1
Open Access
Respiratory Cilia as a Therapeutic Target of Phosphodiesterase Inhibitors
Marta Jošková, Juraj Mokrý, Soňa Fraňová
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 29
Cilia Stimulatory and Antibacterial Activities of T2R Bitter Taste Receptor Agonist Diphenhydramine: Insights into Repurposing Bitter Drugs for Nasal Infections
Li Eon Kuek, Derek B. McMahon, Ray Ma, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 452-452
Open Access | Times Cited: 18
Formulation, design and strategies for efficient nanotechnology-based nasal delivery systems
Cecília Torqueti de Barros, Isabella Portugal, Fernando Batain, et al.
RPS Pharmacy and Pharmacology Reports (2022) Vol. 1, Iss. 1
Open Access | Times Cited: 18
Nose-to-brain drug delivery for the treatment of CNS disease: New development and strategies
Li Du, Lin Chen, Fangfang Liu, et al.
International review of neurobiology (2023), pp. 255-297
Closed Access | Times Cited: 10
Serum Albumin in Nasal Drug Delivery Systems: Exploring the Role and Application
Sandra Aulia Mardikasari, Gábor Katona, Ildikó Csóka
Pharmaceutics (2024) Vol. 16, Iss. 10, pp. 1322-1322
Open Access | Times Cited: 3
Nanocarrier facilitated drug delivery to the brain through intranasal route: A promising approach to transcend bio-obstacles and alleviate neurodegenerative conditions
K. Trideva Sastri, N. Vishal Gupta, M Sharadha, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 75, pp. 103656-103656
Closed Access | Times Cited: 14
<p>Current Understanding of Nasal Epithelial Cell Mis-Differentiation</p>
Agmal Scherzad, Rudolf Hagen, Stephan Hackenberg
Journal of Inflammation Research (2019) Vol. Volume 12, pp. 309-317
Open Access | Times Cited: 24
Nasal Mucociliary Clearance in Smokers: A Systematic Review
Awal Prasetyo, Udadi Sadhana, Jethro Budiman
International Archives of Otorhinolaryngology (2020) Vol. 25, Iss. 01, pp. e160-e169
Open Access | Times Cited: 23
Nasal route for antibiotics delivery: Advances, challenges and future opportunities applying the quality by design concepts
Sandra Aulia Mardikasari, Bence Sipos, Ildikó Csóka, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 77, pp. 103887-103887
Closed Access | Times Cited: 13
Epithelial cell dysfunction in chronic rhinosinusitis: the epithelial–mesenchymal transition
Jing Yuan, Ming Wang, Chengshuo Wang, et al.
Expert Review of Clinical Immunology (2023) Vol. 19, Iss. 8, pp. 959-968
Closed Access | Times Cited: 7
CFD-PK model for nasal suspension sprays: Validation with human adult in vivo data for triamcinolone acetonide
Rabijit Dutta, Arun V. Kolanjiyil, Ross Walenga, et al.
International Journal of Pharmaceutics (2024) Vol. 665, pp. 124660-124660
Closed Access | Times Cited: 2
Challenges in the Development and Application of Organ-on-Chips for Intranasal Drug Delivery Studies
Muhammad Usman Khan, Xinyu Cai, Zhiwei Shen, et al.
Pharmaceutics (2023) Vol. 15, Iss. 5, pp. 1557-1557
Open Access | Times Cited: 6
Short peptide sequence enhances epithelial permeability through interaction with protein kinase C
Sakthikumar Ragupathy, Joël Brunner, Gerrit Borchard
European Journal of Pharmaceutical Sciences (2021) Vol. 160, pp. 105747-105747
Open Access | Times Cited: 13
Localized delivery of nanomedicine and antibodies for combating COVID-19
Bin Tu, Yanrong Gao, Xinran An, et al.
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1828-1846
Open Access | Times Cited: 9
Novel nasal formulation of xylometazoline with hyaluronic acid: In vitro ciliary beat frequency study
Larisa Tratnjek, Laura Simić, Karina Vukelić, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2023) Vol. 192, pp. 136-146
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top